REPLICATION COMPETENT RETROVIRUS TESTING (RCR) IN THE NATIONAL GENE VECTOR BIOREPOSITORY: NO EVIDENCE OF RCR IN 1595 POST-TREATMENT PERIPHERAL BLOOD SAMPLES OBTAINED FROM 60 CLINICAL TRIALS

By sjmartinez • December 16, 2022

Cornetta K, Yao J, House K, Duffy L, Adusumilli PS, Beyer R, Booth C, Brenner M, Curran K, Grilley B, Heslop H, Hinrichs CS, Kaplan RN, Kiem HP, Kochenderfer J, Kohn DB, Mailankody S, Norberg SM, O'Cearbhaill RE, Pappas J, Park J, Ramos C, Ribas A, Rivièra I, Rosenberg SA, Sauter C, Shah N, Slovin SF, Thrasher A, Williams DA, Lin TY. REPLICATION COMPETENT RETROVIRUS TESTING (RCR) IN THE NATIONAL GENE VECTOR BIOREPOSITORY: NO EVIDENCE OF RCR IN 1595 POST-TREATMENT PERIPHERAL BLOOD SAMPLES OBTAINED FROM 60 CLINICAL TRIALS. Mol Ther. 2022 Dec 13:S1525-0016(22)00710-9. doi: 10.1016/j.ymthe.2022.12.006. Epub ahead of print. PMID: 36518078.

Tags: Hematology/Oncology, Publications

Related Posts

Phase Ib/II trial of anti-CD33 monoclonal antibody BI 836858 and azacitidine in previously untreated older acute myeloid leukemia patients: Beat AML S2 sub-study results

Hochman MJ, Ruppert AS, Huang Y, Mims A, Borate U, Swords R, Traer E, Baer MR, Duong VH, Stock W, Odenike T, Patel P, Madanat[...]

Phase II randomised study of magrolimab combined with bevacizumab-FOLFIRI in patients with previously treated advanced inoperable metastatic colorectal cancer

Fakih M, Gill S, Sampat K, Chan DL, Fisher G, Cruz-Correa M, Lenz HJ, Garcia-Alfonso P, Forget F, Lonardi S, Krauss J, Chen E, Cubillo[...]

Clinical Outcomes of Lentiviral Vector Gene Therapy for Sickle Cell Disease

Prueksapraopong C, Fernandes A, Campo Fernandez B, Roy S, Hollis RP, Habtemariam B, Pellin D, Ceoldo G, Lin TY, Dang TT, Cornetta K, Romero Z,[...]